Trends in Survival Rates of Non–Small Cell Lung Cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020

IMPORTANCE: Over the past 10 years, treatment of non–small cell lung cancer (NSCLC) has been continually revolutionized. However, standard clinical trials may not reflect current multiple lines of treatment and corresponding outcomes in a timely manner. OBJECTIVE: To investigate outcomes associated...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, Sang Ah, Yu, Hyeyeon, Choi, Yoon-La, Park, Sehhoon, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Ahn, Myung-Ju, Choi, Dae-Ho, Kim, Kyunga, Jung, Hyun Ae, Park, Keunchil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020884/
https://www.ncbi.nlm.nih.gov/pubmed/36929402
http://dx.doi.org/10.1001/jamanetworkopen.2023.2002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020884/
https://www.ncbi.nlm.nih.gov/pubmed/36929402
http://dx.doi.org/10.1001/jamanetworkopen.2023.2002

Ejemplares similares